|
ABBOTT LABORATORIES ARCHITECT STAT TROPONIN-I REAGENT KIT; IMMUNOASSAY METHOD, TROPONIN SUBUNIT
|
Back to Search Results |
|
| Catalog Number |
02K41-37 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/14/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
The customer observed falsely elevated architect stat troponin-i results for three patients.The following data was provided (customer¿s cut off for males is 0.000-0.033 ng/ml; for females is 0.000-0.013 ng/ml): sample id (b)(6), male, initial result, on (b)(6) 2023, was 0.014, repeats were 0.579 and 0.010 ng/ml.Sample id (b)(6), female, initial result, on (b)(6) 2023, was 0.239, repeats were 0.000 and 0.000 ng/ml.Sample id (b)(6), male, initial result, on (b)(6) 2023, was 0.147, repeat was 0.015 ng/ml.There was no impact to patient management reported.
|
| |
|
Additional Manufacturer Narrative
|
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Section a1 - patient identifier complete entry = sample id (b)(6), sample id (b)(6), and sample id (b)(6).All available patient information was included.Additional patient details are not available.
|
| |
|
Additional Manufacturer Narrative
|
|
The complaint investigation for falsely elevated architect stat troponin-i results included a search for similar complaints, and the review of complaint text, trending data, labeling, and device history records.Trending review determined no related trend for the issue for the product.The historical performance of the lot 73237un23 was evaluated using worldwide data for the troponin-i assay.The patient median data (divided into 3 groups) and cal f rlu mean were analyzed and compared to an established control limit.This evaluation indicated that all three levels of the patient medians and the cal f rlu mean for the lot 73237un23 are within the established limits.Return testing was not completed as returns were not available.Device history record review did not identify any non-conformances or deviations with the likely cause lot and complaint issue.Manufacturing documentation for the likely cause lot was reviewed and did not identify any issues.Labeling was reviewed and sufficiently addresses the customer's issue.Based on the information provided and abbott diagnostics¿ complaint investigation, no systemic issue or deficiency of architect stat troponin-i, lot number 73237un23, was identified.
|
| |
|
Event or Problem Description
|
|
The customer observed falsely elevated architect stat troponin-i results for three patients.The following data was provided (customer¿s cut off for males is 0.000-0.033 ng/ml; for females is 0.000-0.013 ng/ml): sample id (b)(6) , male, initial result, on (b)(6) 2023, was 0.014, repeats were 0.579 and 0.010 ng/ml sample id (b)(6) , female, initial result, on (b)(6) 2023, was 0.239, repeats were 0.000 and 0.000 ng/ml sample id (b)(6) , male, initial result, on (b)(6) 2023, was 0.147, repeat was 0.015 ng/ml.There was no impact to patient management reported.
|
| |
|
Search Alerts/Recalls
|
|
|